首页> 外文OA文献 >Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

【2h】

Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

机译：Tegaserod，一个5-HT4受体部分激动剂，缓解胃痛，膨胀和便秘肠症患者的肠易肠综合征患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
S. A. Müller-Lissner; I. Fumagalli; K. D. Bardhan; F. Pace; E. Pecher; B. Nault; P. Rüegg;
展开▼
作者单位

展开▼
年度 2001
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Tegaserod: a serotonin 5-HT4 receptor agonist for treatment of constipation-predominant irritable bowel syndrome. [J] . Cole P, Rabasseda X Drugs of today: Medicamentos de actualidad . 2004,第12期

机译：Tegaserod：5-羟色胺5-HT4受体激动剂，用于治疗以便秘为主的肠易激综合征。
2. Tegaserod: a novel, selective 5-HT4 receptor partial agonist for irritable bowel syndrome. [J] . Beglinger C International journal of clinical practice . 2002,第1期

机译：Tegaserod：一种用于肠易激综合症的新型选择性5-HT4受体部分激动剂。
3. Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation [J] . Chang L., Chey W. D., Drossman D., Alimentary pharmacology & therapeutics. . 2016,第10期

机译：便秘性肠易激综合征患者基线腹痛和腹胀对卢比前列酮反应的影响
4. MOTILITY DISORDERS IN HUMANS: SLOW TRANSIT CONSTIPATION AND IRRITABLE BOWEL SYNDROME [C] . Gianrico Farrugia American College of Veterinary Internal Medicine Forum . 2008

机译：人类的动力障碍：缓慢过境便秘和肠肠综合征
5. Effects of a Novel AI Mobile App on Symptom Severity in Subjects with Irritable Bowel Syndrome: A Randomized Controlled Trial [D] . Rafferty, Aaron Joseph. 2020

机译：一种新的AI流动应用对肠易激综合征症状严重程度的影响：随机对照试验
6. Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation [O] . L. Chang, W. D. Chey, D. Drossman, -1

机译：便秘性肠易激综合征患者基线腹痛和腹胀对卢比前列酮反应的影响
7. The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation:a clinical study [O] . Bardhan, K D, Forbes, A, Marsden, C L, 2004

机译：腹痛/不适，腹胀和便秘的肠易激综合征患者停用替加色龙治疗与连续治疗的临床研究

Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

著录项

引文网络

相似文献

相关主题

期刊订阅